EcoDrugPlus

Ensembl ID : ENSCHYG00000022830
Gene Symbol: -
Cross references: -
131 Possible Orthologues:

Ensembl ID : ENSCHYG00000023024
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSCHYG00000023148
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSCHYG00000004290
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Ensembl ID : ENSCHYG00000022260
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSCHYG00000022959
Gene Symbol: -
Cross references: -
296 Possible Orthologues:

Ensembl ID : ENSCHYG00000023270
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSCHYG00000023637
Gene Symbol: -
Cross references: -
241 Possible Orthologues:

Ensembl ID : ENSCHYG00000004262
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSCHYG00000025418
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSCHYG00000025686
Gene Symbol: -
Cross references: -
52 Possible Orthologues:

Ensembl ID : ENSCHYG00000026087
Gene Symbol: -
Cross references: -
52 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).